Your browser doesn't support javascript.
loading
Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data.
Abril, Maria K; Khanna, Ashish K; Kroll, Stew; McNamara, Connor; Handisides, Damian; Busse, Laurence W.
Afiliação
  • Abril MK; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Emory University, Atlanta, GA, United States.
  • Khanna AK; Anesthesiology Institute, Department of General Anesthesiology & Center for Critical Care, Cleveland Clinic, Cleveland, OH, United States; Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, United States. Electronic address: ashish@or.org.
  • Kroll S; La Jolla Pharmaceutical Company, San Diego, CA, United States.
  • McNamara C; Anesthesiology Institute, Department of General Anesthesiology & Center for Critical Care, Cleveland Clinic, Cleveland, OH, United States.
  • Handisides D; La Jolla Pharmaceutical Company, San Diego, CA, United States.
  • Busse LW; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Emory University, Atlanta, GA, United States.
J Crit Care ; 50: 188-194, 2019 04.
Article em En | MEDLINE | ID: mdl-30553989

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque / Choque Séptico / Vasoconstritores / Angiotensina II Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque / Choque Séptico / Vasoconstritores / Angiotensina II Idioma: En Ano de publicação: 2019 Tipo de documento: Article